Quantcast
Last updated on April 18, 2014 at 7:07 EDT

Latest Interstitial lung disease Stories

2011-08-04 15:00:00

BRISBANE, Calif., Aug. 4, 2011 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced results from operations for the second quarter and six months ended June 30, 2011. InterMune also highlighted its recent business and clinical development activities, as well as the status of preparations for the launches of Esbriet® (pirfenidone) in the European Union. Dan Welch, Chairman, Chief Executive Officer and President of InterMune said, "The second quarter was...

2011-07-28 07:00:00

BRISBANE, Calif., July 28, 2011 /PRNewswire/ -- InterMune (NASDAQ: ITMN) today announced that it will release its second quarter 2011 financial results on Thursday, August 4, 2011. A live conference call and webcast will be hosted by InterMune at 4:30 p.m. Eastern time that same day to discuss business highlights and financial results for the second quarter and first six months of 2011. To access the live teleconference, dial 888-567-5125 (U.S.) or 706-643-9223 (international), conference...

2011-07-25 10:00:00

Awards Given for Research, Humanitarian and Advocacy Efforts CULVER CITY, Calif., July 25, 2011 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) proudly announces the winners of its three annual awards for distinguished service. Each honoree has contributed in a significant way to the effort to fight Pulmonary Fibrosis (PF) - in research, humanitarian and advocacy efforts. This year's recipients are renowned PF researcher Kevin Flaherty, MD, CPF Board of Directors...

2011-07-19 16:19:03

Patients with idiopathic pulmonary fibrosis (IPF) who report treatment for gastroespophageal reflux (GER) appear to have longer survival than IPF patients who are not treated for GERD, according to a new study from the University of California, San Francisco. "While preliminary, these findings support a relationship between GER, chronic microaspiration and IPF," said lead researcher Joyce Lee, MD, clinical instructor in the Department of Medicine at UCSF. Microaspiration occurs when gastric...

2011-07-12 16:24:00

Landmark Bill Introduced in Senate and House Would Create National Patient Registry, Increase Public Awareness of Lethal Lung Disease WASHINGTON, July 12, 2011 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced today the Pulmonary Fibrosis Research Enhancement Act (PFREA) has been introduced in the Senate by Senators Chris Coons (D-DE) and Mike Crapo (R-ID) in the U.S. House of Representatives by Rep. Erik Paulsen (R-MN) and Rep. Tammy Baldwin (D-WI). The...

2011-07-12 14:00:00

Landmark Legislation Will Coordinate and Expand National Research on Pulmonary Fibrosis CHICAGO, July 12, 2011 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced today the re-introduction of the Pulmonary Fibrosis Research Enhancement Act (PFREA). Bi-partisan Lead Sponsors, Senators Christopher Coons (D-DE), Mark Kirk (R-IL), Michael Crapo (R-ID), and Patty Murray (D-WA) and Representatives Erik Paulson (R, MN-3) and Tammy Baldwin (D, WI-2) made the announcement...

2011-07-07 16:59:00

BRISBANE, Calif., July 7, 2011 /PRNewswire/ -- InterMune (NASDAQ: ITMN) today announced that patient enrollment has begun in ASCEND, a new Phase 3 study of pirfenidone for patients who suffer from idiopathic pulmonary fibrosis (IPF). ASCEND is a multinational, randomized, double-blind, placebo controlled Phase 3 trial designed to evaluate the safety and efficacy of Esbriet® (pirfenidone) in IPF patients with mild to moderate impairment in lung function. The primary...

2011-07-05 10:00:00

PF Week Set for Sept. 18-24 CULVER CITY, Calif., July 5, 2011 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced today it has set its 2011 National Pulmonary Fibrosis (PF) Awareness Week for September 18-24, 2011. The primary goals of this year's activity are to support the Pulmonary Fibrosis Research Enhancement Act (PFREA) that will soon be introduced and to raise awareness of PF issues to Members of Congress and in communities nationwide, while...

2011-07-02 02:49:20

    * Patients with a form of pulmonary fibrosis often do not get referred to a tertiary care center quickly.     * Delayed access is associated with a higher death rate.     * Better methods of early detection would shorten time from first symptoms to referral. Idiopathic pulmonary fibrosis (IPF)"•scarring and thickening of the lungs from unknown causes"•is the predominant condition leading to lung transplantation nationwide. Columbia...

2011-06-29 12:00:00

Guy Junker and Stan Savran to Help Launch the First Violet Rippy 5K Walk/Run for the Coalition for Pulmonary Fibrosis PITTSBURGH, June 29, 2011 /PRNewswire-USNewswire/ -- Former SPORTSBEAT Co-Hosts Guy Junker and Stan Savran will reunite to host the first Violet Rippy 5K Walk/Run for Pulmonary Fibrosis. The event will be held at the North Shore Riverfront Park in Pittsburgh on Saturday, August 13, 2011 and will benefit the Coalition for Pulmonary Fibrosis (CPF). Junker and Savran, both...